Documents A First-in-human, First-in-class, Phase I Study of Systemic Hedgehog Pathway Antagonist, GDC-0449,.....

Slide 1A First-in-human, First-in-class, Phase I Study of Systemic Hedgehog Pathway Antagonist, GDC-0449, in Patients with Advanced Solid Tumors P.M. LoRusso, C.M. Rudin,…